RNU6-1314P

Across TCGA pan-cancer cohorts, RNU6-1314P RNA is linked to patient survival in 4 of 34 cancer types, making it the most broadly survival-associated RNU6-1314P data layer.

The strongest signal is observed in sarcoma (SARC), where higher RNU6-1314P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU6-1314P expression acts as an unfavorable survival marker.

SARC, SKCM, and PRAD are the cancer types where RNU6-1314P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
SARC	OS	Tertile	All	0.022	0.861	<.001	36	view →
SKCM	DFS	Tertile	All	0.211	0.728	.023	27	view →
PRAD	DFS	Tertile	All	0.726	0.937	.017	18	view →
STAD	DFS	Tertile	II,III,IV	0.228	0.543	.011	18	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

RNU6-1314P–SARC (OS)

Open the SARC breakdown →